Estracyt and erythema multiforme Patient Reports February 13, 2012

Estracyt Side Effects Report #5099788-9
Estracyt side effect was reported by a Health Professional from JAPAN on Aug 10, 2006. Male patient, 76 years of age, was diagnosed with prostatic specific antigen increased, prostate cancer recurrent and was treated with Estracyt. After drug was administered, patient experienced the following side effects: conjunctivitis, erythema multiforme, pharyngeal erythema, prostate cancer recurrent. Estracyt dosage: unknown. During the same period patient was treated with DIFENIDOL HYDROCHLORIDE, BICALUTAMIDE, ETIZOLAM, KALLIDINOGENASE, EPINASTINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Estracyt Side Effects Report #5101354-3
Estracyt side effect was reported by a Health Professional from JAPAN on Aug 10, 2006. Male patient, 76 years of age, was diagnosed with prostatic specific antigen increased, prostate cancer recurrent and was treated with Estracyt. After drug was administered, patient experienced the following side effects: conjunctivitis, erythema multiforme. Estracyt dosage: 560 MG, ORAL. During the same period patient was treated with DIFENIDOL HYDROCHLORIDE, BICALUTAMIDE, ETIZOLAM, KALLIDINOGENASE, EPINASTINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Estracyt Side Effects Report #5030664-3
Estracyt side effect was reported by a Health Professional from JAPAN on May 25, 2006. Male patient, 76 years of age, was diagnosed with prostate cancer  and was treated with Estracyt. After drug was administered, patient experienced the following side effects: erythema multiforme. Estracyt dosage: 560 MG, ORAL. Patient was hospitalized. Patient recovered.